Answers are grounded in this paper and cite their sources.
Transcranial ultrasound stimulation (TUS), as a neuromodulation technology, can improve the progression of Alzheimer's disease (AD). However, the regulatory mechanisms of TUS on the AD network level have not yet been fully studied. Combining a theoretical model of intramembrane cavitation with animal experiments, this study systematically explored the modulatory effects of ultrasound stimulation on network activity in AD mice. The research results show that: 1) TUS can improve the abnormal discharge of AD pyramidal neurons; 2) TUS enhances the inhibitory drive of interneurons in the CA1 network, improving information exchange and neural oscillation activities within the network. Finally, by applying TUS to APP/PS1 mice for 4 consecutive weeks, we demonstrated that TUS strengthens the inhibition within the network and achieves a regulatory effect on neural oscillations. Our results indicate that TUS mitigates AD neural network cognitive dysfunction primarily by enhancing inhibitory plasticity and rebalancing the hippocampal excitation-inhibition (E/I) imbalance. This study provides a mechanistic foundation for the clinical application of transcranial ultrasound as a precise neural circuit-level therapy for the treatment of AD.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: